Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
Abstract Cancer vaccines are less effective at old than at young age because of immunosenescence. Besides, in preliminary observations we showed that the immunization with HER-2/neu DNA plasmid in transgenic young mice (standard immunization, SI) delays but not abrogate spontaneous mammary tumours p...
Saved in:
Main Authors: | Mauro Provinciali, Alessandra Barucca, Fiorenza Orlando, Elisa Pierpaoli |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/30a26d3f0af04239af09033dd04f3b15 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
by: Maral Mokhtari, et al.
Published: (2021) -
Cancer biomarker HER-2/neu in breast cancer in Indian women
by: Singhai R, et al.
Published: (2011) -
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
by: Salkeni MA, et al.
Published: (2021) -
Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting
by: Matthew M Seavey, et al.
Published: (2009) -
Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
by: Prasenjit Das, et al.
Published: (2021)